OIM
Oracle Investment Management Portfolio holdings
AUM
$116M
This Quarter Return
-2.13%
1 Year Return
+84.31%
3 Year Return
+539.5%
5 Year Return
+791.07%
10 Year Return
+13,222.09%
AUM
$681M
AUM Growth
+$681M
(-14%)
Cap. Flow
-$56.7M
Cap. Flow
% of AUM
-8.33%
Top 10 Holdings %
Top 10 Hldgs %
93.38%
Holding
35
New
2
Increased
2
Reduced
15
Closed
9
Top Buys
| 1 |
Pfizer
PFE
|
$28M |
| 2 |
Cross Country Healthcare
CCRN
|
$1.97M |
| 3 |
CFRX
ContraFect Corporation
CFRX
|
$693K |
| 4 |
Forian
FORA
|
$178K |
Top Sells
| 1 |
Vir Biotechnology
VIR
|
$13.4M |
| 2 |
Atea Pharmaceuticals
AVIR
|
$10.8M |
| 3 |
Y-mAbs Therapeutics
YMAB
|
$9.01M |
| 4 |
Guardant Health
GH
|
$8.75M |
| 5 |
QuidelOrtho
QDEL
|
$6.96M |
Sector Composition
| 1 | Healthcare | 100% |
| 2 | Energy | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BHVN
1
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $286M | 40.64% | 2,075,402 -48,653 | -2% | -$6.7M |
|
|
2
QuidelOrtho
QDEL
$1.95B
| $115M | 16.4% | 855,068 -51,587 | -6% | -$6.96M |
|
3
Opko Health
OPK
$1.1B
| $58.8M | 8.35% | 12,219,073 -600,000 | -5% | -$2.89M |
|
|
4
Vir Biotechnology
VIR
$686M
| $36.1M | 5.12% | 861,008 -320,349 | -27% | -$13.4M |
|
|
AGEN
5
Agenus
AGEN
$133M
| $29.3M | 4.17% | 9,106,132 -331,202 | -4% | -$1.07M |
|
6
Pacific Biosciences
PACB
$393M
| $29.1M | 4.14% | 1,420,652 -24,307 | -2% | -$498K |
|
|
7
Pfizer
PFE
$141B
| $28M | 3.99% | +475,000 | New | +$28M |
|
8
BioCryst Pharmaceuticals
BCRX
$1.74B
| $23.1M | 3.29% | 1,670,733 -250,000 | -13% | -$3.46M |
|
|
AXDX
9
DELISTED
Accelerate Diagnostics
AXDX
| $18.9M | 2.69% | 3,627,549 -123,572 | -3% | -$645K |
|
|
10
Forian
FORA
$61.3M
| $11M | 1.56% | 1,219,661 +19,701 | +2% | +$178K |
|
|
AWH
11
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
| $9.82M | 1.4% | 5,547,094 -3,100,000 | -36% | -$5.49M |
|
|
DMTK
12
DELISTED
DermTech, Inc. Common Stock
DMTK
| $9.53M | 1.35% | 602,907 -9,400 | -2% | -$149K |
|
|
CDAK
13
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
| $7.34M | 1.04% | 659,191 -40,809 | -6% | -$455K |
|
|
ATRS
14
DELISTED
Antares Pharma, Inc.
ATRS
| $6.14M | 0.87% | 1,720,000 -180,000 | -9% | -$643K |
|
|
CFRX
15
DELISTED
ContraFect Corporation
CFRX
| $5.14M | 0.73% | 1,952,422 +263,520 | +16% | +$693K |
|
|
IMMP
16
Immutep
IMMP
$234M
| $3.2M | 0.46% | 976,156 -23,844 | -2% | -$78.2K |
|
|
17
Cross Country Healthcare
CCRN
$438M
| $1.97M | 0.28% | +71,000 | New | +$1.97M |
|
18
Soleno Therapeutics
SLNO
$3.6B
| $874K | 0.12% | 2,132,000 | – | – |
|
19
Biogen
BIIB
$19.4B
| $579K | 0.08% | 2,412 | – | – |
|
20
Performance Technologies
PTIX
$3.13M
| $416K | 0.06% | 300,267 -199,733 | -40% | -$277K |
|
|
MOTS
21
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
| $49K | 0.01% | 105,885 -2,841,666 | -96% | -$1.32M |
|
|
AMRN
22
Amarin Corp
AMRN
$311M
| – | – | -838,403 | Closed | -$4.28M |
|
23
ARK Genomic Revolution ETF
ARKG
$1.04B
| – | – | 0 | – | – |
|
|
24
Atea Pharmaceuticals
AVIR
$267M
| – | – | -309,126 | Closed | -$10.8M |
|
25
Biodesix
BDSX
$62.6M
| – | – | -180,833 | Closed | -$1.49M |
|